ArticlePharmaceutics2022

Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress.

Anabel Torrente-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.